Advertisement
Screener

RALLYBIO CORPORATION (RLYB) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

RALLYBIO CORPORATION Earnings Per Share (Basic)

RALLYBIO CORPORATION (RLYB) reported Earnings Per Share (Basic) of $7.66 per share for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-08-26.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-08-26

  • RALLYBIO CORPORATION earnings per share, basic for the quarter ending 2026-06-30 was $7.66.
  • RALLYBIO CORPORATION earnings per share, basic for the quarter ending 2026-03-31 was -$1.46.
  • RALLYBIO CORPORATION earnings per share, basic for the quarter ending 2025-09-30 was $0.36.
  • RALLYBIO CORPORATION earnings per share, basic for the quarter ending 2025-06-30 was -$1.73.
  • RALLYBIO CORPORATION earnings per share, basic for fiscal 2023 was -$1.84.
  • RALLYBIO CORPORATION earnings per share, basic for fiscal 2022 was -$2.09.
  • RALLYBIO CORPORATION earnings per share, basic for fiscal 2021 was -$1.84.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 3 month as first filedEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 6 month as first filedEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 12 monthEarnings Per Share, Basic 12 month as first filed
2026-06-30$7.66
S-4/A · filed 2026-08-26
$6.21
S-4/A · filed 2026-08-26
2026-03-31-$1.46
S-4 · filed 2026-07-15
2025-12-31-$1.59
S-4/A · filed 2026-08-26
2025-09-30$0.36
10-Q · filed 2025-11-06
-$0.07
10-Q · filed 2025-11-06
2025-06-30-$1.73
S-4/A · filed 2026-08-26
-$0.22
10-Q · filed 2025-08-07
-$3.42
S-4/A · filed 2026-08-26
-$0.43
10-Q · filed 2025-08-07
2025-03-31-$1.69
S-4 · filed 2026-07-15
-$0.21
10-Q · filed 2025-05-08
2024-12-31-$10.61
S-4/A · filed 2026-08-26
-$1.33
10-K · filed 2025-03-13
2024-09-30-$0.26
10-Q · filed 2025-11-06
-$1.08
10-Q · filed 2025-11-06
2024-06-30-$0.37
10-Q · filed 2025-08-07
-$0.83
10-Q · filed 2025-08-07
2024-03-31-$0.47
10-Q · filed 2025-05-08
2023-12-31-$1.84
10-K · filed 2025-03-13
2023-09-30-$0.45
10-Q · filed 2024-11-07
-$1.35
10-Q · filed 2024-11-07
2023-06-30-$0.46
10-Q · filed 2024-08-08
-$0.89
10-Q · filed 2024-08-08
2023-03-31-$0.43
10-Q · filed 2024-05-09
2022-12-31-$2.09
10-K · filed 2024-03-12
2022-09-30-$0.60
10-Q · filed 2023-11-09
-$1.65
10-Q · filed 2023-11-09
2022-06-30-$0.57
10-Q · filed 2023-08-08
-$1.05
10-Q · filed 2023-08-08
2022-03-31-$0.48
10-Q · filed 2023-05-09
2021-12-31-$1.84
10-K · filed 2023-03-06
2021-09-30-$0.37
10-Q · filed 2022-11-07
-$1.44
10-Q · filed 2022-11-07
2021-06-30-$0.49
10-Q · filed 2022-08-08
-$1.09
10-Q · filed 2022-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Anixa Biosciences Inc (ANIX)United States$0.096B
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Lifevantage Corp (LFVN)United States$0.078B15.40